NASDAQ: DVAX - Dynavax Technologies Corporation

Yield per half year: +25.58%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Dynavax Technologies Corporation

Extended chart Simple chart
Financial Markets by TradingView

About Dynavax Technologies Corporation

Dynavax Technologies Corporation, биофармацевтическая компания, специализируется на разработке и коммерциализации новых вакцин в Соединенных Штатах. Компания продает HEPLISAV-B, вакцину против гепатита B для предотвращения инфекции, вызываемой всеми известными подтипами вируса гепатита B, в возрасте 18 лет и старше в Соединенных Штатах и Европе. Он также производит и продает CpG 1018, адъювант, используемый в HEPLISAV-B. Корпорация Dynavax Technologies заключила соглашение о сотрудничестве с Valneva Scotland Limited; соглашение с Serum Institute of India Pvt. Ltd .

more details
; и сублицензионное соглашение с Merck, Sharp & Dohme Corp. Компания ранее была известна как Double Helix Corporation, а в сентябре 1996 года изменила свое название на Dynavax Technologies Corporation. Dynavax Technologies Corporation была зарегистрирована в 1996 году, ее штаб-квартира находится в Эмеривилле, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2004-02-19
ISIN US2681582019
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.dynavax.com
Цена ао 13.63
Change price per day: -2.54% (13.98)
Change price per week: -0.11% (13.64)
Change price per month: +1.53% (13.42)
Change price per 3 month: +6.11% (12.84)
Change price per half year: +25.58% (10.85)
Change price per year: +9.79% (12.41)
Change price per 3 year: +17.86% (11.56)
Change price per 5 year: +465.35% (2.41)
Change price per year to date: +6.11% (12.84)
All parameters

Underestimation

Title Value Grade
P/S 6.17 1
P/BV 2.87 6
P/E 62.65 1
EV/EBITDA -452.49 0
Total: 4.5

Efficiency

Title Value Grade
ROA, % 2.75 1
ROE, % 4.48 1
Total: 2.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -60.71 10
Total: 6

Growth impulse

Title Value Grade
Yield Revenue, % 489.89 10
Yield Ebitda, % -91.2 0
Yield EPS, % -126.26 0
Total: 2
More

Institutions Volume Share, %
Blackrock Inc. 23 17.72
State Street Corporation 11 8.11
Vanguard Group Inc 9 7.18
Deep Track Capital, LP 9 6.98
Federated Hermes, Inc. 8 6.1
Chicago Capital, LLC 6 4.31
Kynam Capital Management, LP 4 3.24
Goldman Sachs Group Inc 4 3.19
Dimensional Fund Advisors LP 4 3.1
Geode Capital Management, LLC 3 2.23

ETFShare, %Profitability for 1 year, %Dividends, %
Amplify Treatments Testing and Advancements ETF 3.47 10.31 1.06
Virtus LifeSci Biotech Products ETF 1.38736 36.79 0.13953
ETC 6 Meridian Small Cap Equity ETF 1.16224 19.38 1.95746
Invesco S&P SmallCap Health Care ETF 1.06616 10.25 0.41696
Invesco S&P SmallCap 600® Pure Growth ETF 0.59529 32.37 1.34638
ETC 6 Meridian Low Beta Equity ETF 0.42496 22.48 2.13049
Royce Quant Small‑Cap Quality Value ETF 0.35027 21.83 1.62596
Direxion Daily S&P Biotech Bull 3x Shares 0.29442 4067.92 0.25924
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.28305 18.2 1.66828
Vanguard S&P Small-Cap 600 Growth ETF 0.24 30.31 1.37064
SPDR S&P 600 Small Cap Growth ETF 0.22875 14.13 1.33495
Timothy Plan US Small Cap Core ETF 0.20649 30.16 1.63049
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 0.19443 1.54 0.22433
JPMorgan Diversified Return U.S. Small Cap Equity ETF 0.18674 26.04 2.20258
VictoryShares US Discovery Enhanced Volatility Wtd ETF 0.17872 21.4 1.67826
VictoryShares US Small Cap Volatility Wtd ETF 0.17821 30.08 1.67818
Syntax Stratified SmallCap ETF 0.17642 13.51 1.639
SPDR S&P SmallCap 600 ESG ETF 0.16895 18.95 1.85316
Avantis U.S Small Cap Equity ETF 0.16317 27.77 1.68271
Future Tech ETF 0.14569 426.34 0.8416
Principal Healthcare Innovators ETF 0.14569 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.145 28.58 0.8565
SPDR Portfolio S&P 600 Small Cap ETF 0.1139 13.05 1.84119
Vanguard S&P Small-Cap 600 ETF 0.11 13.46 1.89226
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.1058 31.36 1.41955
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.09872 24.75 1.59225
ProShares Ultra Nasdaq Biotechnology 0.0975 51.7 0.85651
Vanguard Russell 2000 Growth ETF 0.09 23.05 0.60264
iShares Russell 2000 Growth ETF 0.0884 38.04 0.6026
ProShares Ultra SmallCap600 0.07969 49.8 1.83727
WisdomTree U.S. SmallCap Fund 0.06565 15.03 1.80258
Vanguard Russell 2000 ETF 0.05 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.03896 17.47 1.51433
iShares Morningstar Small-Cap Growth ETF 0.03425 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.03425 587.89 0.72598
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.0338 17.58 1.75869
Dimensional U.S. Targeted Value ETF 0.03238 26.01 1.93487
ProShares UltraPro Russell2000 0.03231 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.03229 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.03229 30.1 1.60498
iShares Morningstar Small Cap Value ETF 0.02974 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.02974 201.65 2.50476
iShares U.S. Tech Breakthrough Multisector ETF 0.02705 21.8 0.73986
Fidelity MSCI Health Care Index ETF 0.02063 3 1.46057
Avantis Responsible U.S. Equity ETF 0.01837 26.78 1.45257
Invesco S&P SmallCap 600 Revenue ETF 0.01528 30.92 1.94562
Dimensional U.S. Core Equity 2 ETF 0.01179 30.76 1.47098
SPDR Portfolio MSCI Global Stock Market ETF 0.0113 17.99 2.19607
Dimensional US Marketwide Value ETF 0.01063 24.88 2.11042
Humankind US Stock ETF 0.0106 18.81 1.99919
ProShares Hedge Replication ETF 0.009 5.92 1.47892
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00844 21.94 1.69572
Avantis U.S. Equity ETF 0.0056 23.04 1.59151
Dimensional US Core Equity Market ETF 0.00472 30.98 1.40618
SPDR S&P 1500 Value Tilt ETF 0.00396 27.15 2.3833
iShares Russell 3000 ETF 0.00287 24.83 1.43482
Dimensional U.S. Equity ETF 0.00271 31.53 1.3557
Schwab U.S. Broad Market ETF 0.0027 24.86 1.43354
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.0025 24.29 1.46083
SPDR S&P 1500 Momentum Tilt ETF 0.00014 38.25 1.12176
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.211261.46



Head Job title Payment Year of birth
Mr. Ryan Spencer CEO & Director 1.25M 1978 (47 years)
Mr. David F. Novack President & COO 925.6k 1962 (63 years)
Ms. Kelly MacDonald Senior VP & CFO 674.27k 1984 (41 year)
Mr. Justin Burgess Chief Accounting Officer & Controller N/A
Mr. Jeff P. Coon Senior VP & Chief Human Resources Officer N/A 1963 (62 years)
Mr. Donn Casale Senior VP & Chief Commercial Officer N/A
Mr. Paul Cox VP of Investor Relations & Corporate Communications N/A
Dr. Dong Yu Senior Vice President of Vaccine Research N/A
Dr. Robert Janssen M.D. Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory Affairs 1954 (71 year)
Mr. John L. Slebir Senior VP & General Counsel 1966 (59 years)

Address: United States, EmeryVille, CA , 2100 Powell Street - open in Google maps, open in Yandex maps
Website: https://www.dynavax.com